Shockwave Medical Stock News

Pioneer of IVL Selected as the Second Most Innovative Medical Device Company Pioneer of IVL Selected as the Second Most Innovative Medical Device Company

Shockwave Medical's (SWAV) fourth-quarter results reflect robust revenue growth and expansion in gross margin.

Shockwave Medical's (SWAV) fourth-quarter results reflect robust revenue growth and expansion in gross margin.

Over the past 3 months, 4 analysts have published their opinion on ShockWave Medical (NASDAQ:SWAV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding

Over the past 3 months, 4 analysts have published their opinion on ShockWave Medical (NASDAQ: SWAV ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 2 0 0 Last 30D 0 1 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 1 0 0 3M Ago 0 1 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, ShockWave Medical has an average price target of $208.5 with a high of … Full story available on Benzinga.com

Over the past 3 months, 4 analysts have published their opinion on ShockWave Medical (NASDAQ:SWAV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding

DKNG and SHAK dropped after each gave disappointing guidance in their latest quarterly updates. DE and SWAV both rose following earnings news.

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Agios's Metabolic Disorder Treatment Receives FDA Approval (NASDAQ: AGIO) said the U.S. Food and Drug

Shockwave Medical Inc''s (NASDAQ: SWAV ) fourth-quarter FY21 sales were up 271% Y/Y to $84.2 million , beating the consensus of $75.43 million. The revenue growth was primarily driven by the launch of the coronary product, Shockwave C2, sales force expansion in the U.S., and increased penetration in both U.S. & international markets. Gross … Full story available on Benzinga.com

SWAV earnings call for the period ending December 31, 2021.

SWAV earnings call for the period ending December 31, 2021.

It was a tough day on Wall Street overall.

Benzinga’s after-hours earnings roundup aims to deliver quick details about a company's earnings report, its forward-looking guidance and any other notable details. The list is handpicked by the rep

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 385.71% and 11.85%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?